logo

For the Inventor, By the Inventor

Pittsboro, NC, United States of America

Richard Ray Tidwell

This inventor holds 69 USPTO granted patents and 2 published patent applications, primarily in Antiparasitic Agents (CPC class 5142). Top assignees: The University of North Carolina at Chapel Hill, The Georgia State University Research Foundation, Inc., Duke University. Active years: 1982-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard Ray Tidwell. Retrieved from https://idiyas.com/inventor/richard-ray-tidwell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 69 

% Patents Active = 71.0

Average Co-Inventor Count = 4.3

ph-index = 12

Forward Citations = 447(Granted Patents)

Forward Citations (Not Self Cited) = 349(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Pittsboro, GA (US) (2000)
  • Chapel Hill, NC (US) (1982 - 2004)
  • Pittsboro, NC (US) (1996 - 2019)

Company Filing History:

goldMedal54 out of 1,326 
 
The University of North Carolina at Chapel Hill
 patents
silverMedal40 out of 205 
 
The Georgia State University Research Foundation, Inc.
 patents
bronzeMedal13 out of 2,078 
 
Duke University
 patents
4. 9 out of 414 
 
Auburn University
 patents
5. 2 out of 359 
 
Research Triangle Institute
 patents
6. 1 out of 224 
 
The University of North Carolina at Charlotte
 patents
7. 1 out of 2,169 
 
University of Washington
 patents
8. 13 out of 834,453 
Other
 patents
where one patent can have more than one assignee

Years Active: 1982-2019

Loading Chart...
Areas of Expertise:
Antiparasitic Compounds
Dicationic Agents
Antimicrobial Activity
Prodrugs
Neurological Pathogens
Antifungal Activity
BVDV Treatment
Mixed Nucleic Acid Recognition
Retroviral Integrase Inhibition
Fused Ring Compounds
Imidazo Compounds
Benzamidoxime Prodrugs
69 patents (USPTO):Explore Patents
1. 10399966 - Compounds for treatment of trypanosomes and neurological pathogens and uses thereof (2019-09-03),
2. 8188121 - Substituted pyridines as antiparasitic AZA teraryl compounds (2012-05-29),
3. 8101636 - Linear dicationic terphenyls and their aza analogues as antiparasitic agents (2012-01-24),
4. 7964619 - Teraryl components as antiparasitic agents (2011-06-21),
5. 7951827 - Synthesis and antiprotozoal activity of dicationic 3,5-diphenylisoxazoles (2011-05-31),
6. 7825279 - Fused ring dicationic anti-protozoan agents and their prodrugs (2010-11-02),
7. 7745456 - Synthesis and antimicrobial activity of novel dicationic 'reversed amidines' (2010-06-29),
8. 7517893 - Bichalcophenes and their prodrugs as antiprotozoal agents (2009-04-14),
9. 7432278 - Dicationic imidazo[1,2-a]pyridines and 5,6,7,8-tetrahydro-imidazo[1,2-a]pyridines as antiprotozoal agents (2008-10-07),
10. 7417158 - Cationic substituted benzofurans as antimicrobial agents (2008-08-26),
11. 7410999 - Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection (2008-08-12),
12. 7410989 - Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection (2008-08-12),
13. 7256203 - Dicationic 2,5-diarylfuran aza-analogs as anti-protozoan agents (2007-08-14),
14. 7241795 - Synthesis and antimicrobial activity of novel dicationic 'reversed amidines' (2007-07-10),
15. 7183286 - Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection (2007-02-27),

Title: The Inventor Spotlight: Richard Ray Tidwell

Introduction:

Richard Ray Tidwell, a prolific inventor based in Pittsboro, NC (US), has made significant contributions to the field of pharmaceuticals with an impressive portfolio of 54 patents.

Latest Patents:

Tidwell's recent patents include groundbreaking innovations such as "Compounds for treatment of trypanosomes and neurological pathogens and uses thereof," which highlights novel compounds effective in combating neurological pathogens like trypanosomes. Another notable invention is "Substituted pyridines as antiparasitic AZA teraryl compounds," showcasing his expertise in developing compounds to combat microbial infections.

Career Highlights:

Tidwell has showcased his inventiveness while working at esteemed institutions such as the University of North Carolina at Chapel Hill and Georgia State University Research Foundation, Inc. His dedication to research and development in the pharmaceutical domain has led to impactful discoveries aimed at enhancing treatment options for various disorders.

Collaborations:

Throughout his career, Tidwell has collaborated closely with esteemed colleagues, including David W Boykin and W David Wilson. These collaborations have been instrumental in driving innovation and pushing the boundaries of pharmaceutical research.

Conclusion:

In conclusion, Richard Ray Tidwell stands as a pioneering inventor in the pharmaceutical industry, with a remarkable track record of patents that have the potential to revolutionize treatment methodologies. His collaborative spirit and relentless pursuit of innovation continue to inspire breakthroughs in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…